Avro Life Science
Avro Life Science, based in Waterloo, ON, Canada, specializes in developing skin patches for generic drug delivery within the healthcare sector, particularly focusing on Drug Discovery and Delivery.
Company Overview
Avro Life Science is a healthcare company based in Waterloo, Ontario, Canada. The company operates in the drug discovery and delivery sub-industry, focusing on innovative solutions for drug delivery through skin patches. With a team of 8 members, Avro Life Science is advancing healthcare by developing technologies that enable novel classes of drugs to be passively delivered into the skin. As a clinical-stage biotech, it aims to redefine the skin’s potential as a therapeutic medium.
Y Combinator W18 Batch Participant
Avro Life Science was part of the prestigious Y Combinator Winter 2018 (W18) batch. Participation in Y Combinator provided the company with an opportunity to accelerate its growth through access to mentorship, funding, and a network of fellow innovators. This affiliation has helped Avro Life Science gain valuable insights and foster connections within the startup ecosystem.
Affiliations and Collaborations
Avro Life Science maintains affiliations with several notable organizations, including Bayer, Thiel Fellowship, Velocity, Creative Destruction Lab, University of Waterloo, Mitacs, Ontario Centres of Excellence (OCE), and California Life Sciences. These partnerships have facilitated the company's research and development efforts, providing support and collaboration opportunities to advance their drug delivery technologies.
Innovative Drug Delivery Platforms
The company's pipeline includes several innovative platforms and products aimed at revolutionizing drug delivery. These include the TopiqIL Platform and the TransdermIL Platform, designed to utilize the skin as a therapeutic vector. Additionally, product candidates such as AVR 235 and AVR 335 are part of their development efforts to bring new treatment options to market. These platforms highlight Avro Life Science's commitment to advancing non-invasive drug delivery methods.
Regional Operations
Operating primarily in Canada and the broader North American region, Avro Life Science benefits from its strategic location in Waterloo, Ontario. This regional focus allows the company to collaborate with local institutions and industry partners, as well as leverage regional resources to support its healthcare innovations.